DA - CIMA - Enfermedades cardiovasculares - Aterosclerosis e inflamación - Artículos de revista : [118]

Browse
Subscribe to this collection to receive daily e-mail notification of new additions RSS Feed RSS Feed RSS Feed
Collection's Items (Sorted by Submit Date in Descending order): 1 to 20 of 118
Issue DateTitleTypeAuthor(s)
2015Serum tissue inhibitor of matrix metalloproteinase-1 levels are associated with mortality in patients with malignant middle cerebral artery infarctionArticuloLorente, L. (Leonardo); Martin, M.M. (María M.); Ramos, L. (Luis), et al
2013The 372 T/C genetic polymorphism of TIMP-1 is associated with serum levels of TIMP-1 and survival in patients with severe sepsisArticuloLorente, L. (Leonardo); Martin, M. (Mar); Plasencia, F. (Fátima), et al
Apr-2014Association between serum tissue inhibitor of matrix metalloproteinase-1 levels and mortality in patients with severe brain trauma injuryArticuloLorente, L. (Leonardo); Martin, M.M. (María M.); Lopez, P. (Patricia), et al
11-Apr-2014Association of sepsis-related mortality with early increase of TIMP-1/MMP-9 ratioArticuloLorente, L. (Leonardo); Martin, M.M. (María M.); Sole-Violan, J. (Jordi), et al
2009Maintained effectiveness of an electronic alert system to prevent venous thromboembolism among hospitalized patientsArticuloLecumberri, R. (Ramón); Marques, M. (Margarita); Diaz-Navarlaz, M.T. (María Teresa), et al
2008A new favourable effect of cocoa on atherosclerosis?ArticuloParamo, J.A. (José Antonio)
2009Hemorragia, hemostasia y trombosis en cirugíaArticuloParamo, J.A. (José Antonio)
2001Atherosclerosis: Is it time for a new name?ArticuloParamo, J.A. (José Antonio); Beloqui, O. (Óscar); Diez-Martinez, J. (Javier)
2011The hemostatic system as a modulator of atherosclerosisArticuloParamo, J.A. (José Antonio)
2005Trombosis arterial y polimorfismos genéticos: demasiados actores, escenario complejoArticuloParamo, J.A. (José Antonio); Lecumberri, R. (Ramón); Orbe, J. (Josune)
1994Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgeryArticuloRocha, E. (Eduardo); Hidalgo, F. (Francisco); Llorens, R. (Rafael), et al
1984Activador tisular del plasminógeno. Mecanismo de acción y propiedades trombolíticasArticuloParamo, J.A. (José Antonio); Collen, D. (D.)
1986Enfermedad tromboembólica y modificaciones de la coagulación tras artroplastia total de cadera. Acción de la profilaxis con ácido acetilsalicílico o heparina-dihidroergotaminaArticuloAlfaro, M.J. (M.J.); Paramo, J.A. (José Antonio); Pablos, J. (Julio) de, et al
1982Alteraciones de la fibrinoformación en la cirrosis hepáticaArticuloFernandez, J. (Javier); Narvaiza, M.J. (M.J.); Cuesta, B. (Braulia), et al
1996Development and clinical application of a new ELISA assay to determine plasmin-alpha2-antiplasmin complexes in plasmaArticuloMontes, R. (Ramón); Paramo, J.A. (José Antonio); Angles-Cano, E. (Eduardo), et al
1991Thrombin activation and increased fibrinolysis in patients with chronic liver diseaseArticuloParamo, J.A. (José Antonio); Rifon, J. (Jose); Fernandez, J. (Javier), et al
2010Matrix metalloproteinases and their inhibitors as biomarkers of severity in sepsisArticuloLorente, L. (Leonardo); Martin, M.M. (María M.); Sole-Violan, J. (Jordi), et al
2004Validation of plasma fibrinogen as a marker of carotid atherosclerosis in subjects free of clinical cardiovascular diseaseArticuloParamo, J.A. (José Antonio); Beloqui, O. (Óscar); Roncal, C. (Carmen), et al
2007Tratamiento del síndrome antifosfolípidoArticuloParamo, J.A. (José Antonio); Garcia, R. (R.); Rodriguez, P. (P.), et al
2005Role of von Willebrand factor levels in the prognosis of stage IV colorectal cancer: do we have enough evidence?ArticuloGil-Bazo, I. (Ignacio); Diaz-Gonzalez, J.A. (Juan Antonio); Rodriguez, J. (Javier), et al
Collection's Items (Sorted by Submit Date in Descending order): 1 to 20 of 118